Biotech BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update May 17, 2026
Biotech Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success May 16, 2026
Biotech Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer’s Disease May 14, 2026
Biotech Natural Field Unveils NFco-Loading® Healthy Aging Innovation at Vitafoods Europe 2026 May 13, 2026
Biotech Sino Biological Unveils EliteScience VIP Partnership Program for European Researchers May 11, 2026
Biotech ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D May 10, 2026
Biotech Inhibrx To Host Webcast Presentation to Provide Clinical Update on INBRX-106 HexAgon Study in First Line HNSCC May 9, 2026
Biotech Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor May 8, 2026